DHX37 and gastric adenocarcinoma: However, the opposite results were observed in lung squamous cell carcinoma (P = 0.0065), rectum adenocarcinoma (P = 0.0023), stomach adenocarcinoma (P = 0.0091), uterine corpus endometrial carcinoma (P = 0.023), and thyroid carcinoma(P = 0.0015), in which the high expression of DHX37 was correlated with favorable prognosis.